Nationwide Survey on Acute Complications of Type 1 Diabetes Conducted - Ketoacidosis and Severe Hypoglycemia Persist During Treatment
NQ Score
50/100
N1 Content Completeness
9
AI Summary (NQ-processed)
A nationwide survey conducted by the Japan Diabetes Society revealed that even among type 1 diabetes patients undergoing insulin therapy, 7.8% have experienced ketoacidosis and 12.7% have experienced severe hypoglycemia. These acute complications were more frequent in patients with low endogenous insulin secretion. This study, based on 2019 data, suggests the importance of disseminating advanced therapies such as continuous glucose monitoring and developing treatments aimed at preserving pancreatic β-cell function.
AI Analysis
Frequently Asked Questions
- Q: What are the main findings of this survey?
- A: It revealed that among type 1 diabetes patients in Japan receiving insulin therapy, 7.8% had experienced ketoacidosis and 12.7% had experienced severe hypoglycemia, which are life-threatening acute complications.
- Q: What are the characteristics of patients prone to acute complications?
- A: Patients with significantly reduced endogenous insulin secretion from their own pancreas (low C-peptide levels) and those with a long duration of insulin therapy tended to have a higher rate of experiencing complications.
- Q: When and how was this survey conducted?
- A: It was conducted from November to December 2019, targeting 4,405 type 1 diabetes patients visiting 125 medical institutions nationwide, using an electronic data capture system.
- Q: What do the survey results suggest?
- A: They indicate that serious complications persist even under insulin therapy, suggesting the importance of further disseminating advanced device therapies like insulin pumps and continuous glucose monitors, and developing new treatments to preserve pancreatic β-cell function.
- Q: Where were these research findings published?
- A: They were published in the international academic journal 'Journal of Diabetes Investigation' on April 8, 2026.